Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
Elumalai Appachi, MBBS. MRCP (UK), DCH, FAAP, is currently a staff member in Cleveland Clinic Children’s Hospital Department of Pediatric Critical Care Medicine.
Dr. Appachi is board certified in pediatrics and pediatric critical care and is a member of the Royal College of Physicians. He completed his medical degree at Stanley Medical College at Madras University in Madras, India. His post-graduate training includes a pediatric internship and a pediatric critical care residency with Cleveland Clinic.
Dr. Appachi is a Fellow of the American Academy of Pediatrics as well as a Fellow of the Society of Critical Care Medicine. He is a past-president of the Northern Ohio Pediatric Society.
He has been recognized by The Royal Manchester Children’s Hospital as Best Teacher of the Year; he has received Teacher of the Year Award from Cleveland Clinic Children’s Hospital; and he has been recognized multiple years in a row in “Best Doctors in America,” which is an on-line resource developed by Best Doctors Inc.
In addition to his clinical practice, Dr. Appachi is an established basic researcher and has published multiple research articles in peer-reviewed journals on topics such as pediatric anesthesia, pediatric head and neck surgery, and pediatric thoracic surgery, among others.
Dr. Appachi also directs the medical simulation program at the Children's hospital and has developed the innovative Just-in time simulation-based training for the healthcare professionals at the Children's Hospital.
His specialty interests include pediatric cardiac critical care, metabolic disorders, and medical education.
Specialty Interests
pediatric critical care medicine, pediatric metabolic disorders
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/6/2013, Dr. Appachi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.